Determining IgA and IgG antigliadin, IgA antitransglutaminase, and antiendomysial antibodies in monkey esophagus and in umbilical cord for diagnosis of celiac disease in developing countries

Serologic screening of celiac disease in adolescents

OBJECTIVE

This study aimed to identify the seroprevalence of celiac disease in adolescents from public schools in the city of Salvador, Bahia.

METHODS

This was a cross-sectional study with probabilistic sample of 1,213 adolescents, aged 11 to 17 years old, of both genders. The body mass index was used to determine the participants' nutritional status based on the percentiles for age and gender recommended by the World Health Organization. Measurement of the anti-human transglutaminase immunoglobulin A (anti-tTG-IgA) antibody was established as the specific screening test for celiac disease, which involved an enzyme-linked immunosorbent assay (ELISA). Descriptive analysis was performed using proportions and means (standard deviation).

RESULTS

The female gender prevailed in the sample, and most of the participants had normal weights. The anti-tTG-IgA antibody was positive in 6/1,213 (0.49%) adolescents.

CONCLUSION

The seroprevalence of celiac disease was 0.49% in the investigated adolescents. Further studies are necessary to establish the prevalence of celiac disease in this age range.

[Study of prevalence of celiac disease in children with type 1 diabetes mellitus: result of 10 years of follow-up]

OBJECTIVE

To estimate the prevalence of celiac disease (CD) in children and adolescents with type 1 diabetes mellitus (T1DM) treated in the Children's Division of Endocrinology, at the Universidade Federal de Minas Gerais Hospital das Clínicas.

SUBJECTS AND METHODS

Children and adolescents diagnosed with T1DM, aged 0 to 18 year, were included in this study performed from March 1999 to April 2009. All patients were screened for CD at their first visit and, again, annually. The investigation was performed through the measurement of IgA (AGAA) and IgG (AGAG) antigliadin antibodies. Patients with values of AGAA and/or AGAG above two times the cutoff mark undertook intestinal biopsy.

RESULTS

A group of 21 patients were excluded from the initial total of 384 patients. Out of the remaining, 50 patients had positive serology and 29 underwent intestinal biopsy. The prevalence index was 3.1%.

CONCLUSION

The periodic screening of CD in diabetic patients should be encouraged, due to its high prevalence.

Exposure to respirable flour dust and gliadin in wheat flour mills

OBJECTIVES

The aim of this study was to determine the concentrations of respirable flour dusts and gliadin as well as gliadin-specific serum antibodies in exposed workers of Hamadan wheat flour mill factories.

METHODS

Blood samples from 95 exposed workers and 80 air samples from flour packing, husk packing, flour production and wheat unloading areas were collected. Respirable flour dust density was measured by a gravimetric method, and dust gliadin concentration as well as serum antibodies were determined by enzyme-linked immunosorbent assays.

RESULTS

The Time-weighted average (TWA) flour dust density was higher in all factories (1.56-4.68 mg/m(3)) compared with the threshold limit value (0.5 mg/m(3)) of ACGIH and showed a positive correlation with the gliadin concentration (p<0.05). Additionally, the respirable dust and gliadin concentrations were significantly higher at flour packing workstations compare with the other work areas. Moreover, the mean serum gliadin-specific IgA and IgG and total IgE antibodies were remarkably higher in exposed mill workers compared with the controls (p<0.05).

CONCLUSION

We clearly demonstrated that workers in Hamadan flour mills are in exposed to a hazardous level of respirable flour dust, receiving the highest level of dust and gliadin in flour packing areas. Furthermore, dust-exposed workers showed upper levels of serum antibodies indicating exposure to higher amounts of allergens than controls.

Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil

CONTEXT

Patients with autoimmune rheumatologic conditions and celiac disease tend to have a variety of autoantibodies, many of which have no clear pathogenic role. The literature contains frequent reports of celiac disease being more prevalent in patients with rheumatologic diseases, although this remains controversial.

OBJECTIVES

To investigate the prevalence of positive serum tests for celiac disease, particularly IgA and IgG antigliadin (AGA) antibodies and IgA antiendomysium antibodies (EmA) in patients with autoimmune rheumatologic diseases. A second aim was to correlate positive serum tests with prednisone and immunosuppressant medication.

METHODS

A total of 190 adults and pediatric patients with a variety of autoimmune rheumatologic diseases (systemic lupus erythematosus, rheumatoid arthritis, juvenile rheumatoid arthritis and spondyloarthrophathies) were evaluated and tested for IgA and IgG antigliadin-antibodies and IgA antiendomysium antibodies. Patients with positive serum tests underwent endoscopic duodenal biopsies for pathology studies.

RESULTS

There were four positive sera (2.1%) for AGA IgA, all of which tested negative for AGA IgG and EmA. Three sera (1.6%) tested positive for AGA IgG; all were negative for AGA IgA and EmA. The EmA test at a 1:2.5 serum dilution tested positive in 94 patients (49.5%); at a 1:5 serum dilution it was positive in 41 patients (21.6%). Eleven subjects tested positive for EmA at 1:40 dilution; and all of these tested negative for IgA tissue antitransglutaminase (tTG) antibodies. Nine of the 11 EmA-positive patients and all 7 patients with positive antigliadin antibodies tests underwent duodenal endoscopic biopsies, and no significant changes were demonstrated in their duodenal mucosa. A positive EmA was associated with elevated optical density AGA IgA readings; however, there was no relationship between positive EmA and AGA IgG optical density readings. Prednisone and immunosuppressant use were unrelated to AGA IgA optical density readings or AGA IgG readings. These drugs were associated with fewer positive EmA tests.

CONCLUSIONS

Positive AGAA, AGAG or EmA results are probably nonspecific for the presence of celiac disease among autoimmune rheumatologic disease patients. The intake of prednisone and immunosuprressant drugs seems to reduce the prevalence of IgA EmA, but it does not interfere with antigliadin antibodies tests.Further studies are required to estimate more accurately the prevalence of this disease in rheumatologic patients.